FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

14223211000001109: Erythromycin ethyl succinate 500mg tablets 12 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
50577901000001111 Erythromycin ethyl succinate 500mg tablets 12 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
50578001000001113 Erythromycin ethyl succinate 500mg tablets 12 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythromycin ethyl succinate 500mg tablets 12 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets 12 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets 12 tablet Is pack of Product containing precisely erythromycin 500 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets 12 tablet Has active ingredient Erythromycin ethylsuccinate false Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets 12 tablet Has active ingredient Erythromycin false Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets 12 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets 12 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets 12 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets 12 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets 12 tablet Has VMP Product containing precisely erythromycin 500 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets 12 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets 12 tablet Has specific active ingredient Erythromycin ethylsuccinate true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets 12 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets 12 tablet Has basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Erythroped A 500mg tablets (Sigma Pharmaceuticals Plc) 12 tablet Is a True Erythromycin ethyl succinate 500mg tablets 12 tablet Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Sigma Pharmaceuticals Plc) 12 tablet Is a True Erythromycin ethyl succinate 500mg tablets 12 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start